Overall rank by patents
#887
Across all tracked assignees
USPTO PatentsView assignee record - 511 granted patents across 190 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).
The verdict
Jiangnan holds 511 US patents across 190 technology areas, rank #887 of 50,000 tracked assignees.
Jiangnan University has been granted 511 US utility patents between 2015 and 2025, placing Jiangnan University at rank #887 across all assignees tracked by PlainPatent. This portfolio spans 190 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.4 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Jiangnan University is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Jiangnan sits between Bayer Intellectual Property Gmbh (513 patents, rank #883) and Nuvasive, Inc. (504 patents, rank #891) - the closest US assignees by grant volume. The composite Innovation Score of 59.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 404 grants, compared with 107 in the 2015–2019 window, a +278% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Jiangnan University's 8.4 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Jiangnan University against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Bayer Intellectual Property GmbH
513 patents
DISH Technologies L.L.C.
512 patents
EMORY UNIVERSITY
512 patents
KENNAMETAL INC.
512 patents
NICOVENTURES TRADING LIMITED
511 patents
SUMITOMO METAL MINING CO., LTD.
511 patents
Jiangnan University
511 patents
ENTEGRIS, INC.
509 patents
NuVasive, Inc.
504 patents
What this shows Jiangnan holds 511 patents at rank #887, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #887 in granted patent volume.
Other assignees with the most granted patents in Jiangnan's primary technology class.
Jiangnan's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
60 Top 4% higher than 96% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 6 | 1.2% |
| 2016 | 11 | 2.2% |
| 2017 | 12 | 2.3% |
| 2018 | 28 | 5.5% |
| 2019 | 50 | 9.8% |
| 2020 | 57 | 11.2% |
| 2021 | 70 | 13.7% |
| 2022 | 68 | 13.3% |
| 2023 | 72 | 14.1% |
| 2024 | 82 | 16.0% |
| 2025 | 55 | 10.8% |
Top 15 of 190 technology areas
Overall rank by patents
#887
Across all tracked assignees
59.9 out of 100
How to use this portfolio
Jiangnan's 511 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.